文献速递分子诊断临床微生物

肠杆菌目分离株分子耐药机制广谱检测方法的比较评估

Comparative Evaluation of Assays for Broad Detection of Molecular Resistance Mechanisms in Enterobacterales Isolates.
PubMed 文献 · J Clin Microbiol · 2021-08-18

本研究以全基因组测序为参考标准,比较了两种多重PCR试剂(Streck ARM-D β-内酰胺酶试剂盒和OpGen Acuitas AMR基因面板u5.47(研究用))及一种微阵列(Check-MDR CT103XL)对65株肠杆菌目分离株的广谱耐药基因检测性能。三种方法与测序总体一致性均高,其中OpGen Acuitas AMR与测序结果总体一致性最高;各方法主要差异在于靶标数量和多样性(Streck 9个,OpGen 34个)。

要点

  • 三种商业化分子方法对肠杆菌目耐药基因检测与全基因组测序总体一致性均高。
  • OpGen Acuitas AMR与测序结果的总体一致性最高。
  • 各方法主要差异为靶标数量和多样性,从Streck 9个到OpGen 34个。

核心结论

  • 商业化PCR方法可准确鉴定临床重要革兰阴性菌中的抗菌药物耐药位点。

研究设计与样本

  • 比较两种多重PCR试剂(Streck ARM-D β-内酰胺酶试剂盒、OpGen Acuitas AMR基因面板u5.47(RUO))和一种微阵列(Check-MDR CT103XL),以全基因组测序为参考标准。
  • 纳入65株革兰阴性菌分离株,来自56例患者,经表型药敏试验判定为对β-内酰胺类耐药(ESBL阳性或对第三代头孢菌素或碳青霉烯类耐药)。

主要发现

  • 三种分子方法与测序的总体一致性均高。
  • OpGen Acuitas AMR与测序结果的总体一致性最高。
  • 各方法主要差异在于靶标数量和多样性,Streck为9个,OpGen为34个。

关键数值与推荐

  • OpGen Acuitas AMR基因面板u5.47靶标数为34个。
  • Streck ARM-D β-内酰胺酶试剂盒靶标数为9个。

临床怎么用

  • 在临床实验室中,可采用商业化PCR方法对临床重要革兰阴性菌的耐药位点进行准确鉴定。
  • 尚需进一步研究明确此类方法的临床诊断作用和潜在获益。

局限性

  • 需进一步研究确定此类方法的临床诊断作用和潜在获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rapid detection of antimicrobial resistance in both surveillance and diagnostic settings is still a major challenge for the clinical lab, compounded by the rapid evolution of antibiotic resistance mechanisms. This study compares four methods for the broad detection of antibiotic resistance genes in Enterobacterales isolates: two multiplex PCR assays (the Streck ARM-D beta-lactamase kit and the OpGen Acuitas AMR Gene Panel u5.47 (research use only [RUO]) and one microarray assay (the Check-MDR CT103XL assay), with whole-genome sequencing as a reference standard. A total of 65 Gram-negative bacterial isolates, from 56 patients, classified by phenotypic antimicrobial susceptibility testing (AST) as showing resistance to beta-lactam antimicrobials (extended-spectrum beta-lactamase [ESBL] positive or resistance to third-generation cephalosporins or carbapenems) were included in the study. Overall concordance between the molecular assays and sequencing was high. While all three assays had similar performance, the OpGen Acuitas AMR assay had the highest overall percent concordance with sequencing results. The primary differences between the assays tested were the number and diversity of targets, ranging from 9 for Streck to 34 for OpGen. This study shows that commercially available PCR-based assays can provide accurate identification of antimicrobial resistance loci in clinically significant Gram-negative bacteria. Further studies are needed to determine the clinical diagnostic role and potential benefit of such methods.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Brazelton de Cardenas JN, Garner CD, Su Y, et al. Comparative Evaluation of Assays for Broad Detection of Molecular Resistance Mechanisms in Enterobacterales Isolates. J Clin Microbiol. 2021. PMID: 34406800. doi:10.1128/JCM.01033-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。